Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X


press

Mission Bio wins CYTO Innovation and QB3@953 Amgen Golden Ticket Awards

Mission Bio recently won two awards in June 2016, including the CYTO Innovation Award at CYTO 2016 in Seattle, Washington, and the QB3@953 Amgen Golden Ticket Award. The CYTO Innovation Award recognizes the best presentation from the CYTO 2016 Technology Showcase, which highlights novel technologies for cell analysis that are in early stages of development to commercialization. The QB3@953 Amgen Golden Ticket Award supports the research and development efforts of startups with one year of lab space at the QB3@953 incubator, along with access to the scientific and business expertise from Amgen. Read more


press
Mission Bio Launches Pharma Assay Development Services to Speed Access to New Technologies
press
Mission Bio Announces Yan Zhang as New CEO
press
New Study Precisely Characterizes Tumor Heterogeneity in AML Patients Using Mission Bio’s Tapestri Platform
press
Resistance Mechanisms to FLT3 Inhibitor for AML Characterized Using Mission Bio’s Tapestri Platform in Newly Published Study